FHL-3 Antibodies

Santa Cruz Biotechnology provides a broad selection of FHL-3 monoclonal antibodies for research focused on understanding FHL-3 protein function and cellular roles. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FHL-3, or Four and a Half LIM Domains Protein 3, plays essential roles in cell signaling, differentiation, and development. FHL-3 expression patterns vary across different tissues and contribute to numerous biological pathways. Research has shown FHL-3's significance in developmental biology and disease mechanisms. Current studies explore FHL-3's potential involvement in cancer progression and cardiovascular conditions. Ongoing investigations continue to reveal new functions of FHL-3 in cellular regulation and tissue homeostasis. Understanding FHL-3's molecular interactions provides valuable insights into disease development and potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of FHL-3's role in health and disease.